3-Vinylaniline

Catalog No.: 
ACMGHU274
CAS No.: 
15411-43-5
Molecular Formula: 
C8H9N
Molecular Weight: 
119.17
3-Vinylaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$82.00In stockIn stock
5g97%$303.00In stockIn stock
25g97%$1062.00In stockIn stock
100g97%$3791.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Vinylaniline
IUPAC Name3-vinylaniline
MDL No.MFCD00017105
Molecular FormulaC8H9N
Molecular Weight119.17
SMILESNC1=CC(C=C)=CC=C1
InChI KeyIFSSSYDVRQSDSG-UHFFFAOYSA-N
Synonymm-AMINOSTYRENE | CS-W011211 | A883752 | Benzenamine, 3-ethenyl- | SY014136 | 3-ethenylaniline | 3-Vinylaniline | 3-vinyl-aniline | 3-Vinylaniline, contains KOH as inhibitor, 97% | meta amino vinyl benzene | SCHEMBL250060 | FT-0692280 | MFCD00017105 | DTXS
CAS No.15411-43-5
PubChem CID4260041

Synthetic Route by SureRoute

1. ACMGHU274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACROTL726 route compound structure diagram
    ACROTL726586-39-0In Stock
  2. Then
  3. ACMGHU274 route product structure diagram
    ACMGHU27415411-43-5In Stock
Inquiry

2. ACMGHU274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACROTL726 route compound structure diagram
    ACROTL726586-39-0In Stock
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACMGHU274 route product structure diagram
    ACMGHU27415411-43-5In Stock
Inquiry

3. ACMGHU274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACROTL726 route compound structure diagram
    ACROTL726586-39-0In Stock
  2. Plus
  3. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACMGHU274 route product structure diagram
    ACMGHU27415411-43-5In Stock
Inquiry

Comments (0)